Scarica l'app Stockscreener
1.23
0.82%
0.01
Pre-mercato:
1.24
0.01
+0.81%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRTX Giù?
Forum
Previsione
Frazionamento azionario
Heron Therapeutics Inc Borsa (HRTX) Ultime notizie
Heron Therapeutics (HRTX) COO gains 11,770 shares through RSU conversion - Stock Titan
Heron EVP exercises RSUs into 23,464 common shares | HRTX Insider Trading - Stock Titan
[Form 4] HERON THERAPEUTICS, INC. /DE/ Insider Trading Activity - Stock Titan
Heron Therapeutics (NASDAQ: HRTX) CEO converts 84,810 RSUs to shares - Stock Titan
Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
[ARS] HERON THERAPEUTICS, INC. /DE/ SEC Filing - Stock Titan
Heron Therapeutics (NASDAQ: HRTX) seeks approval for major new equity pools - Stock Titan
Heron Therapeutics (NASDAQ:HRTX) Downgraded by Zacks Research to "Strong Sell" - MarketBeat
Heron Therapeutics (HRTX) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 - Sahm
Heron sets May 11 webcast for Q1 results and business updates - Stock Titan
Heron Therapeutics outlines $173M–$183M 2026 sales targets amid acute care momentum and expanded commercial investment - MSN
Research Analysts Set Expectations for HRTX Q1 Earnings - MarketBeat
HRTX Edges Higher As Insider Ownership Change Draws Attention - StocksToTrade
Heron Therapeutics files $125M mixed securities shelf - MSN
H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $6 - Moomoo
HC Wainwright Cuts Earnings Estimates for Heron Therapeutics - MarketBeat
Heron CEO exercises 13,797 RSUs into shares | HRTX Insider Trading - Stock Titan
Heron Therapeutics (NASDAQ: HRTX) seeks shareholder approval to add 26.56M shares across incentive plans - Stock Titan
Heron Therapeutics (HRTX) Stock: Final Thoughts (-1.75%) 2026-04-16Low Volatility Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Heron Therapeutics, Inc. (HRTX) Stock Analysis: A Promising 352.95% Potential Upside Worth Exploring - DirectorsTalk Interviews
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $3 - Moomoo
EBITDA per share of Heron Therapeutics Inc – LSE:0J4V - TradingView — Track All Markets
Total debt per share of Heron Therapeutics Inc – LSE:0J4V - TradingView — Track All Markets
Pullback Watch: Can Heron Therapeutics Inc expand into new markets2026 Sector Moves & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
What scenarios affect Heron Therapeutics (HRTX) Stock price | Price at $0.81, Up 3.09%Buy Opportunities - Cổng thông tin điện tử tỉnh Tây Ninh
Heron Therapeutics (HRTX) CEO exercises 62,500 RSUs into common stock - Stock Titan
Earnings Miss: How does Heron Therapeutics Inc compare to its peersQuarterly Trade Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Heron Therapeutics Executive Employment Agreements: Key Terms, Termination, and Restrictive Covenants Explained - Minichart
Heron Therapeutics Strengthens Executive Contracts Amid Strategic Focus - TipRanks
Heron Therapeutics (NASDAQ: HRTX) revises executive severance and CIC - Stock Titan
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Analysts - marketbeat.com
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of “Hold” by Analysts - Defense World
HRTX Stock Analysis: Heron Therapeutics Inc. Biotech Stock at $0.8 After Minor Daily Dip - Cổng thông tin điện tử tỉnh Lào Cai
HRTX Stock Price, Quote & Chart | HERON THERAPEUTICS INC (NASDAQ:HRTX) - ChartMill
Q1 Earnings Forecast for HRTX Issued By Northland Securities - MarketBeat
Moving Averages: How does Heron Therapeutics Inc compare to its peersWeekly Risk Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Wall Street Recap: How does Heron Therapeutics Inc compare to its peersTrade Entry Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Vanguard realigns holdings; Heron Therapeutics (HRTX) ownership shown as 0 - Stock Titan
What is Northland Securities' Estimate for HRTX Q3 Earnings? - MarketBeat
If You Invested $1,000 in Heron Therapeutics Inc (HRTX) - Stock Titan
Heron Therapeutics, Inc. (HRTX) Investor Outlook: A 415% Upside Potential In Biotechnology - DirectorsTalk Interviews
Market Trends: Is Heron Therapeutics Inc stock technically oversold2026 Key Highlights & Daily Momentum Trading Reports - baoquankhu1.vn
Clearline Capital LP Increases Holdings in Heron Therapeutics, Inc. $HRTX - MarketBeat
Baker BROS. Advisors LP Purchases New Position in Heron Therapeutics, Inc. $HRTX - MarketBeat
Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring a Promising 346% Potential Upside - DirectorsTalk Interviews
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
HRTX SEC FilingsHeron Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Citigroup Inc. Increases Stock Position in Heron Therapeutics, Inc. $HRTX - MarketBeat
Heron Therapeutics Signals Profitable Growth After Strong Quarter - TipRanks
Earnings Call Summary | Heron Therapeutics(HRTX.US) Q4 2025 Earnings Conference - 富途牛牛
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):